Indeed, across a cohort of 47 DLBCL tumor samples, CD71, GPX4, FSP1, ACSL4, TXN, TRXR1, TRXR2, LRP8, SCLY, and AGPAT3 transcripts were all significantly elevated compared to normal B-cell controls (Fig. 1C). This evidence concerns the gene AIFM2 and diffuse large B-cell lymphoma.